Bubs Australia Limited
Bubs Australia Limited (ASX: BUB) is under the consumer staples sector and is a manufacturer of infant milk in Australia. It is engaged in the sale of infant milk formula and organic infant food products.
FY19 Strategic Priorities (Source: Investor Day Presentation)
The company released its quarterly activities report, wherein it stated that the company established numerous important strategic developments and partnerships during the third quarter and post balance date in April, to strengthen the supply chain, expand channel capacity and increase profitability. The continued strong sales momentum provides the foundation for Deloraine acquisition (100%) and new strategic JV alliances with Beingmate, C2 Capital Partners and Chemist Warehouse.
The company continued its strong growth momentum in revenues from the previous quarter with Q3 gross revenue reported at $11.83 million, up by 103% from the prior corresponding period (pcp).
On the price-performance front, at market close on 17th May 2019, the stock of Bubs Australia Limited was trading at $1.250, with a market capitalisation of $657.37 million. The stock has yielded a significant YTD return of 183.52%, along with substantial returns of 168.75%, 155.45% and 64.33% over the past six months, three months and one-month period, respectively. Its 52-week high price stands at $1.615, with an average trading volume of ~7.59 million.
Elders Limited (ASX: ELD) is engaged in providing a wide range of services, including financial planning, banking, real estate as well as trading of grain, wool and livestock. The company aims to provide agribusiness knowledge and technical expertise to farmers, market players and others operating in the agriculture industry.
Elders will announce the half-yearly results (HY19) for the six months ending 31st March 2019, before market opening on Monday, 20th May 2019.
The financial progress of Elders from FY14 to FY18 remained phenomenal, with the underlying EBIT improving significantly, driven by resetting of the operational strategy, focusing on running a pure-play agribusiness, favourable livestock prices, etc.
Source: Company Presentation
On the price-performance front, at market close on 17th May 2019, the stock of Elders Limited was trading at $6.580, with a market capitalisation of $771.63 million. The stock has yielded a negative YTD return of 5.57%, along with returns of -13.93%, 10.35% and 6.27% over the past six months, three months and one-month period, respectively. Its 52-week high price stands at $9.470, with an average trading volume of 588,437.
Australian Agricultural Company Limited
Australian Agricultural Company Limited (ASX: AAC) is into the production and selling of cattle and beef in Australia.
On the financial performance front, the revenue was up by 11.1% to $219.2 million in H1 FY19 vs $197.2 million on the pcp. The operating profit for the company stood at $24.8 million in H1 FY19 vs $6.8 million on the prior corresponding period. The gearing ratio for AAC remained within a targeted range of 26.8%. The return on capital employed increased to 1.9% as compared to 0.5% in pcp. However, there was a loss in statutory EBITDA of the company during the reported period, primarily driven by a decline in the market value of livestock, increase in the highest value Wagyu herd numbers and decline in lower value composite herd numbers.
Source: Company Presentation
On the price-performance front, at market close on 17th May 2019, the stock of Australian Agricultural Company Limited was trading at $1.130, with a market capitalisation of $675.1 million. The stock has yielded a YTD return of 1.82%, along with significantly volatile returns of 21.74% and -1.75% over the past three months and one-month period, respectively. Its 52-week high price stands at $1.445, with an average trading volume of 1,016,471.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.